Skip to main content

Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  225.93
+4.66 (2.11%)
AAPL  269.15
-2.69 (-0.99%)
AMD  204.86
+6.75 (3.41%)
BAC  54.96
+0.41 (0.75%)
GOOG  302.76
+4.70 (1.58%)
META  661.66
+12.16 (1.87%)
MSFT  480.27
+4.15 (0.87%)
NVDA  172.99
+2.05 (1.20%)
ORCL  183.85
+5.39 (3.02%)
TSLA  474.47
+7.21 (1.54%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.